Literature DB >> 25183099

Antiproliferative and hepatoprotective activity of metabolites from Corynebacterium xerosis against Ehrlich Ascites Carcinoma cells.

Farhadul Islam1, Soby Ghosh1, Jahan Ara Khanam1.   

Abstract

OBJECTIVE: To find out the effective anticancer drugs from bacterial products, petroleum ether extract of Corynebacterium xerosis.
METHODS: Antiproliferative activity of the metabolite has been measured by monitoring the parameters like tumor weight measurement, tumor cell growth inhibition in mice and survival time of tumor bearing mice, etc. Hepatoprotective effect of the metabolites was determined by observing biochemical, hematological parameters.
RESULTS: It has been found that the petroleum ether extract bacterial metabolite significantly decrease cell growth (78.58%; P<0.01), tumor weight (36.04 %; P<0.01) and increase the life span of tumor bearing mice (69.23%; P<0.01) at dose 100 mg/kg (i.p.) in comparison to those of untreated Ehrlich ascites carcinoma (EAC) bearing mice. The metabolite also alters the depleted hematological parameters like red blood cell, white blood cell, hemoglobin (Hb%), etc. towards normal in tumor bearing mice. Metabolite show no adverse effect on liver functions regarding blood glucose, serum alkaline phosphatases, glutamic pyruvic transaminase, glutamic oxaloacetic transaminase activity and serum billirubin, etc. in normal mice. Histopathological observation of these mice organ does not show any toxic effect on cellular structure. But in the case of EAC bearing untreated mice these hematological and biochemical parameters deteriorate extremely with time whereas petroleum ether extract bacterial metabolite receiving EAC bearing mice nullified the toxicity induced by EAC cells.
CONCLUSION: Study results reveal that metabolite possesses significant antiproliferative and hepatoprotective effect against EAC cells.

Entities:  

Keywords:  Anticancer activity; Bacterial metabolite; EAC cells; Hepatoprotective activity; Host toxicity

Year:  2014        PMID: 25183099      PMCID: PMC4025299          DOI: 10.12980/APJTB.4.2014C1283

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  17 in total

1.  Bioassay of Eucalyptus extracts for anticancer activity against Ehrlich ascites carcinoma (eac) cells in Swiss albino mice.

Authors:  Farhadul Islam; Hasina Khatun; Soby Ghosh; M M Ali; J A Khanam
Journal:  Asian Pac J Trop Biomed       Date:  2012-05

2.  The prenylation inhibitor manumycin A reduces the viability of Anaplasma phagocytophilum.

Authors:  Qingming Xiong; Yasuko Rikihisa
Journal:  J Med Microbiol       Date:  2011-02-24       Impact factor: 2.472

3.  Purification, characterizations of a snake guard seeds lectin with antitumor activity against Ehrlich ascites carcinoma cells in vivo in mice.

Authors:  Syed Rashel Kabir; Md Farhadul Islam; Md Jahangir Alom; Md Abu Zubair; Nurul Absar
Journal:  Protein Pept Lett       Date:  2012-03       Impact factor: 1.890

4.  Purification and characterization of a Ca(2+)-dependent novel lectin from Nymphaea nouchali tuber with antiproliferative activities.

Authors:  Syed Rashel Kabir; Md Abu Zubair; Md Nurujjaman; Md Azizul Haque; Imtiaj Hasan; Md Farhadul Islam; Md Tanvir Hossain; Md Anowar Hossain; Md Abdur Rakib; Mohammad Taufiq Alam; Ranajit Kumar Shaha; Md Tofazzal Hossain; Yoshinobu Kimura; Nurul Absar
Journal:  Biosci Rep       Date:  2011-12       Impact factor: 3.840

5.  Preventive effect of ethanol extract of Alpinia calcarata Rosc on Ehrlich's ascitic carcinoma cell induced malignant ascites in mice.

Authors:  Rasida Perveen; Farhadul Islam; Jahanara Khanum; Tanzima Yeasmin
Journal:  Asian Pac J Trop Med       Date:  2012-02       Impact factor: 1.226

6.  Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia.

Authors:  Robert J Kreitman; Martin S Tallman; Tadeusz Robak; Steven Coutre; Wyndham H Wilson; Maryalice Stetler-Stevenson; David J Fitzgerald; Robert Lechleider; Ira Pastan
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

Review 7.  Arginine deprivation as a targeted therapy for cancer.

Authors:  L Feun; M You; C J Wu; M T Kuo; M Wangpaichitr; S Spector; N Savaraj
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

8.  Containment of tumor-colonizing bacteria by host neutrophils.

Authors:  Kathrin Westphal; Sara Leschner; Jadwiga Jablonska; Holger Loessner; Siegfried Weiss
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

9.  Growth inhibition and apoptosis of Ehrlich ascites carcinoma cells by the methanol extract of Eucalyptus camaldulensis.

Authors:  Farhadul Islam; Hasina Khatun; Mahbuba Khatun; Shaikh Mohummad Mohsin Ali; Jahan Ara Khanam
Journal:  Pharm Biol       Date:  2013-10-09       Impact factor: 3.503

Review 10.  Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion.

Authors:  Adit Ben-Baruch
Journal:  Cell Adh Migr       Date:  2009-10-05       Impact factor: 3.405

View more
  2 in total

1.  Antioxidant, cytotoxic and apoptotic activities of the rhizome of Zingiber zerumbet Linn. in Ehrlich ascites carcinoma bearing Swiss albino mice.

Authors:  Hanif Ali; Rumana Yesmin Hasi; Majidul Islam; Md Shajedul Haque; Mustfa F Alkhanani; Atiah H Almalki; Shafiul Haque; R Z Sayyed; Tanzima Yeasmin
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

2.  Effect of Theobroma cacao L. on the Efficacy and Toxicity of Doxorubicin in Mice Bearing Ehrlich Ascites Carcinoma.

Authors:  Priyanka P Patil; Pukar Khanal; Vishal S Patil; Rajitha Charla; Darasaguppe R Harish; Basanagouda M Patil; Subarna Roy
Journal:  Antioxidants (Basel)       Date:  2022-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.